Skip to content
  • Sunday, 26 July 2026
  • 1:47 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Bioengineered Bone Marrow-on-a-Chip Platform Revolutionizes Human Hematopoiesis Research and Drug Toxicity Screening
Stem Cell & Regenerative Medicine

Bioengineered Bone Marrow-on-a-Chip Platform Revolutionizes Human Hematopoiesis Research and Drug Toxicity Screening

Dwi Wanna Jul 24, 2026 0

The human bone marrow is a complex, sequestered organ that serves as the primary engine for the body’s circulatory and…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche: New Insights into the Early Drivers of Clonal Hematopoiesis and Myelodysplastic Syndrome

Dwi Wanna Jul 22, 2026 0

The human bone marrow serves as a prolific biological factory, generating millions of new blood and immune cells every second…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche Drives Early Progression of Myelodysplastic Syndromes and Clonal Hematopoiesis

Dwi Wanna May 16, 2026 0

Every second of every day, the human bone marrow performs a silent biological miracle, generating millions of fresh blood and…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche Drives Early Progression of Clonal Hematopoiesis and Myelodysplastic Syndromes

Dwi Wanna May 1, 2026 0

The human bone marrow is one of the most industrious organs in the body, serving as a biological factory that…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche: New Insights into the Early Drivers of Myelodysplastic Syndromes and Clonal Hematopoiesis

Dwi Wanna Apr 16, 2026 0

The human bone marrow is one of the most industrious environments in the human body, functioning as a biological factory…

Read More
Stem Cell & Regenerative Medicine

Bone Marrow Microenvironment Remodeling Identified as Primary Driver in the Progression of Clonal Hematopoiesis and Myelodysplastic Syndromes

Dwi Wanna Apr 9, 2026 0

The human bone marrow functions as a biological factory of staggering proportions, generating millions of new blood and immune cells…

Read More
Rethinking Evidence Generation for Ultra-Rare DiseasesScientists Uncover How Gene Fusion Droplets Drive Rare Kidney Cancer Progression and Potential New Therapeutic TargetsThe Bridge Between Light and Matter How William Rowan Hamiltons Mathematical Vision Predicted the Quantum WorldBrainstem Neural Circuitry Identified as Key Driver of Hypertension Offering New Avenues for Targeted Treatment
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ